Edmond Pharma, S.r.l.

Istituto Luso Farmaco D'italia S.r.l.

Istituto Luso Farmaco D'italia

Instituto Luso Farmaco D'italia S.r.l.

Instituto Luso Farmaco D'italia S.p.a.

Giancarlo B Fregnan

Elso Manghisi

Giuseppe Cascio

Aldo Salimbeni

Guido Vandoni

Giangiacomo Torri

Roberto Porta

Massimo Nicola

Giovanni Ferni

Marco Inglesi

Salts of a glutathione alkylester and anaminoacids

Inclusion complexes of dipyridamole with beta cyclodextrins in the molar ratio of dipyridamole to cyclodextrin ranging from 1:1 to 1:12 provides higher and more consistent blood concentrations than can be achieved by the dipyridamole alone.

Inclusion complexes of dipyridamole with cyclodextrins

The invention provides novel substituted 2-phenylamino-imidazolines-(2) having hypotensive, bradycardizing and diuretic activities.

Substituted 2-phenylamino-imidazolines-(2) and pharmaceutical

The invention provides novel 4-aryl-5-aminoalkyl-1,3-dioxol-2-ones having hypocholesterolemic, hypolipemic, antiulcer, antihistaminic and antiserotoninic activities.

4-Aryl-5-piperazinoalkyl-1,3-dioxol-2-ones, and compositions

The invention provides novel 4-aryl-5-aminoalkyl-4-thiazolin-2-ones and their salts and complexes which have activity on the central nervous system, the cardio-vascular system, and anti-inflammatory, adrenolytic and anti-ulcer activity.

Certain 4-aryl-5-(4-phenylpiperazino)alkyl-4-thiazolin-2-ones

The invention provides a new class of aminoalkoxyphenoxyalkenones having interesting pharmacological properties.

Phenoxyalkylamines

5-Substituted 2-amino-4-arylthiazoles have interesting properties as anti-inflammatories, antipyretics, analgesics, antibacterials, C.N.S. depressants, anti-ulcer, and anti-cough agents.

Growing community of inventors

Milan, Italy

Giancarlo B Fregnan